| Bile acid receptors in non-alcoholic fatty liver disease Y Li, K Jadhav, Y Zhang Biochemical pharmacology 86 (11), 1517-1524, 2013 | 157 | 2013 |
| Hepatic carboxylesterase 1 is essential for both normal and farnesoid X receptor‐controlled lipid homeostasis J Xu, Y Li, WD Chen, Y Xu, L Yin, X Ge, K Jadhav, L Adorini, Y Zhang Hepatology 59 (5), 1761-1771, 2014 | 133 | 2014 |
| Carboxylesterase 2 prevents liver steatosis by modulating lipolysis, endoplasmic reticulum stress, and lipogenesis and is regulated by hepatocyte nuclear factor 4 alpha in mice Y Li, M Zalzala, K Jadhav, Y Xu, T Kasumov, L Yin, Y Zhang Hepatology 63 (6), 1860-1874, 2016 | 126 | 2016 |
| Reversal of metabolic disorders by pharmacological activation of bile acid receptors TGR5 and FXR K Jadhav, Y Xu, Y Xu, Y Li, J Xu, Y Zhu, L Adorini, YK Lee, T Kasumov, ... Molecular metabolism 9, 131-140, 2018 | 104 | 2018 |
| Metformin limits ceramide-induced senescence in C2C12 myoblasts KS Jadhav, CM Dungan, DL Williamson Mechanisms of ageing and development 134 (11-12), 548-559, 2013 | 77 | 2013 |
| Activating transcription factor 3 in immune response and metabolic regulation K Jadhav, Y Zhang Liver research 1 (2), 96-102, 2017 | 73 | 2017 |
| Hepatocyte ATF3 protects against atherosclerosis by regulating HDL and bile acid metabolism Y Xu, Y Li, K Jadhav, X Pan, Y Zhu, S Hu, S Chen, L Chen, Y Tang, ... Nature metabolism 3 (1), 59-74, 2021 | 43 | 2021 |
| Can you trust your gut? Implicating a disrupted intestinal microbiome in the progression of NAFLD/NASH K Jadhav, TS Cohen Frontiers in Endocrinology 11, 592157, 2020 | 43 | 2020 |
| Carboxylesterase 1 is regulated by hepatocyte nuclear factor 4α and protects against alcohol-and MCD diet-induced liver injury J Xu, Y Xu, Y Li, K Jadhav, M You, L Yin, Y Zhang Scientific reports 6 (1), 24277, 2016 | 42 | 2016 |
| Treadmill exercise training modulates hepatic cholesterol metabolism and circulating PCSK9 concentration in high‐fat‐fed mice S Wen, KS Jadhav, DL Williamson, TC Rideout Journal of lipids 2013 (1), 908048, 2013 | 38 | 2013 |
| Lipocalin‐2 protects against diet‐induced nonalcoholic fatty liver disease by targeting hepatocytes Y Xu, Y Zhu, K Jadhav, Y Li, H Sun, L Yin, T Kasumov, X Chen, Y Zhang Hepatology Communications 3 (6), 763-775, 2019 | 30 | 2019 |
| Hepatic forkhead box protein A3 regulates ApoA-I (apolipoprotein AI) expression, cholesterol efflux, and atherogenesis Y Li, Y Xu, K Jadhav, Y Zhu, L Yin, Y Zhang Arteriosclerosis, thrombosis, and vascular biology 39 (8), 1574-1587, 2019 | 27 | 2019 |
| Trouble with Tribbles-1: Elucidating the mechanism of a genome-wide association study locus KS Jadhav, RC Bauer Arteriosclerosis, thrombosis, and vascular biology 39 (6), 998-1005, 2019 | 22 | 2019 |
| Hepatocytic activating transcription factor 3 protects against steatohepatitis via hepatocyte nuclear factor 4α Y Xu, S Hu, K Jadhav, Y Zhu, X Pan, FC Bawa, L Yin, Y Zhang Diabetes 70 (11), 2506-2517, 2021 | 16 | 2021 |
| Hepatic retinoic acid receptor alpha mediates all‐trans retinoic acid's effect on diet‐induced hepatosteatosis FN Cassim Bawa, Y Xu, R Gopoju, NM Plonski, A Shiyab, S Hu, S Chen, ... Hepatology communications 6 (10), 2665-2675, 2022 | 13 | 2022 |
| Retinoic acid receptor alpha (RARα) in macrophages protects from diet-induced atherosclerosis in mice FN Cassim Bawa, R Gopoju, Y Xu, S Hu, Y Zhu, S Chen, K Jadhav, ... Cells 11 (20), 3186, 2022 | 8 | 2022 |
| Dual activation of bile acid receptors FXR and TGR5 plays a protective role in non‐alcoholic fatty liver disease and atherosclerosis K Jadhav, Y Xu, Y Zhang The FASEB Journal 30, 870.4-870.4, 2016 | 2 | 2016 |
| High lipid concentrations regulate skeletal muscle REDD1 DL Willliamson, CM Dungan, KS Jadhav The FASEB Journal 27, 942.1-942.1, 2013 | 2 | 2013 |
| Abstract MP01: Retinoic Acid Receptor Alpha (Rarα) In Macrophages Protects From Diet-induced Atherosclerosis In Mice FN Cassim Bawa, Y Zhu, R Gopoju, Y Xu, shuwei hu, K Jadhav, Y Zhang Arteriosclerosis, Thrombosis, and Vascular Biology 41 (Suppl_1), AMP01-AMP01, 2021 | 1 | 2021 |
| Genetic variants and metabolic diseases, volume II TS Ahluwalia, K Jadhav, M Szydlowska, S Kajani Frontiers Media SA, 2024 | | 2024 |
